Viroplasms are discrete structures formed in the cytoplasm of rotavirus-infected cells and constitute the replication machinery of the virus. The non-structural proteins NSP2 and NSP5 localize in viroplasms together with other viral proteins, including the polymerase VP1, VP3 and the main inner-core protein, VP2. NSP2 and NSP5 interact with each other, activating NSP5 hyperphosphorylation and the formation of viroplasm-like structures (VLSs). We have used NSP2 and NSP5 fused to the enhanced green fluorescent protein (EGFP) to investigate the localization of both proteins within viroplasms in virus-infected cells, as well as the dynamics of viroplasm formation. The number of viroplasms was shown first to increase and then to decrease with time post-infection, while the area of each one increased, suggesting the occurrence of fusions. The interaction between NSP2 and a series of NSP5 mutants was investigated using two different assays, a yeast two-hybrid system and an in vivo binding/immunoprecipitation assay. Both methods gave comparable results, indicating that the N-terminal region (33 aa) as well as the C-terminal part (aa 131-198) of NSP5 are required for binding to NSP2. When fused to the N and C terminus of EGFP, respectively, these two regions were able to confer the ability to localize in the viroplasm and to form VLSs with NSP2.
INTRODUCTION
After entering the cell, rotaviruses initiate active transcription of viral genes to produce viral mRNAs. Within 2-3 h post-infection, discrete cytoplasmic structures called viroplasms are formed, which contain the non-structural proteins NSP2 and NSP5, together with other viral proteins, including the polymerase, VP1, the guanyltransferase methylase, VP3, and the main inner-core protein, VP2 (Gallegos & Patton, 1989; Zeng et al., 1998) . It is in the viroplasm where the initial steps of viral morphogenesis occur, in a process involving the concerted packaging and replication of the 11 positive-polarity ssRNAs to generate the viral dsRNA genomic segments (Patton & Gallegos, 1990; Wentz et al., 1996; Patton et al., 1997) .
The precise role of the non-structural proteins in viroplasms has not yet been fully characterized. NSP2 is a 35 kDa protein and has been described as a homo-octomer with nucleoside triphosphatase and helix-destabilizing activities (Schuck et al., 2001; Taraporewala et al., , 2002 Jayaram et al., 2002) and a possible role in unwinding of the viral dsRNA (Kattoura et al., 1992; . NSP5 comprises 198 amino acids with a high content of serines and threonines; it is O-glycosylated and highly phosphorylated (Welch et al., 1989; Gonzalez & Burrone, 1991; Afrikanova et al., 1996; Blackhall et al., 1998) . The hyperphosphorylation produces isoforms with apparent molecular masses ranging from 28 to 32-34 kDa, which can be easily visualized by SDS-PAGE. (Afrikanova et al., 1996) . It has recently been reported that NSP5 can bind dsRNA (Vende et al., 2002) . In addition, in viroplasms, NSP5 interacts with other viral proteins such as NSP2 (Poncet et al., 1997; Afrikanova et al., 1998) , VP1 (Afrikanova et al., 1998) and VP2 (Berois et al., 2003) . The in vivo interaction with NSP2 leads to NSP5 hyperphosphorylation and the formation of viroplasm-like structures (VLSs) (Afrikanova et al., 1998; Fabbretti et al., 1999) . We have recently shown that the hyperphosphorylation is the consequence of a cellular kinase that is activated by NSP5 itself in a process resembling autophosphorylation (Eichwald et al., 2002) . serum (Life Technologies). BSC-40 cells were cultured in DMEM supplemented with 10 % newborn calf serum (Hyclone). Rotavirus simian strain SA11 (serotype 3) and porcine strain OSU (serotype 5) were propagated and grown in MA104 cells as previously described (Estes et al., 1979) .
To generate the recombinant rVV/NSP2 virus, BSC-40 cells were infected with recombinant vaccinia virus (rVV) VT7/LacOI (Ward et al., 1995) and transfected with pVOTE.1/NSP2. Selection and amplification were carried out as described by Earl & Moss (1993) . The plasmid vector pVOTE.1 and VT7/LacOI were kindly provided by Bernard Moss (National Institutes of Health, Bethesda, MD).
Calcium phosphate transfection was performed essentially as described by Sambrook et al. (1989) . Briefly, 1?5610 6 cells were plated in 100 mm diameter dishes. Linearized plasmid DNA (6 mg) was resuspended in 50 ml 0?16 TE. Mix A was prepared by addition of 169 ml deionized water, followed by 5 ml 2 M CaCl 2 , 50 ml DNA, added drop by drop, and 26 ml 2 M CaCl 2 . This was then added to 250 ml mix B containing 26 HBS (280 mM NaCl, 10 mM KCl, 1?5 mM sodium phosphate, 12 mM glucose and 50 mM HEPES). The final mix was then added to the cells drop by drop. Cells were incubated overnight and the medium replaced with complete medium supplemented with 500 mg geneticin (G-418) ml 21 (Gibco-BRL, Life Technologies). Clones were picked after 1 week on selective medium.
Plasmid constructs. An NSP2-encoding cDNA fragment, obtained by PCR amplification using specific primers to incorporate NcoI and BamHI restriction sites at the N and C termini, respectively, was cloned into pVOTE.1 (Ward et al., 1995) to obtain the construct pVOTE.1/NSP2. Constructs pT 7 v-NSP5, pT 7 v-D1, pT 7 v-D2, pT 7 v-D3, pT 7 v-D4, pT 7 v-DT, pT 7 v-D1/D2 and pT 7 v-D4T have been described previously (Afrikanova et al., 1998; Fabbretti et al., 1999; Eichwald et al., 2002) . The internal deletion plasmids pT 7 v-D2/D4T, pT 7 v-D2/D3 and pT 7 v-D3/DT were obtained by PCR using specific internal primers and cloned into KpnI and BamHI restriction sites in pcDNA3 (Invitrogen). Construct pEGFP-NSP5 has been previously described (Eichwald et al., 2002) , and pEGFP-NSP2 was obtained by insertion of the NSP2 fragment into pEGFP-N1 (Clontech) using KpnI and BamHI restriction sites. p(1-EGFP-4T), p(1-EGFP-T), p(1-EGFP) and p(EGFP-4T) were obtained by insertion of PCRamplified fragments with EcoRI and BamHI restriction sites for domain 1 and BsrGI and NotI sites for domains 4T or T into pEGFP-N1. Constructs pT 7 v-(1-EGFP-4T), pT 7 v-(1-EGFP-T), pT 7 v-(1-EGFP) and pT 7 v-(EGFP-4T) were obtained by digestion from the constructs described above and cloned into pcDNA3 using restriction sites EcoRI and NotI. To produce yeast two-hybrid bait constructs, fragments corresponding to NSP5 mutants were obtained by PCR using specific primers to incorporate EcoRI and BamHI restriction sites at the N-and C-terminal ends, respectively. All these fragments were cloned into pBMT116 to obtain fusion constructs with LexA. NSP2 was cloned into the pVP16/D vector as a BssHII-XbaI fragment to generate the pVP16/NSP2 fusion construct (Visintin et al., 1999) .
Oligonucleotides. The specific primers used for amplifying NSP2 were 59-GATCCGTAGTCTAGAG-39 and 59-TCGACTCTAGAGTACG-39. The specific primers for amplifying pT 7 v-D2/D4T were 59-CGG-GGTACCATGTCTCTCAGC-39 and 59-CGCGGATCCTTAAGTTG-AGATTGAT-39; for pT 7 v-D3/DT, 59-CGGGGTACCATGTCTCTC-AGC-39 and 59-CGCGGATCCTTAGTACTTTTTCTTA-39; and for pT 7 v-D2/D3, 59-CGGGGTACCATGTCTCTCAGC-39 and 59-GCG-GGATCCTTACAAATCTTCGATC-39. The specific primers used for amplifying p(1-EGFP-4T), p(1-EGFP-T), p(1-EGFP) and p(EGFP-4T) were 59-CCGGAATTCATGTCTCTCAGCATTG-39 and 59-CGCGG-ATCCGCAGATTTTCCAGA-39 for region 1; and 59-CGGTGTACA-TTGATAATAAAGAG-39 and 59-TAAAGCGGCCGCTTACAAATCT-TCGATC-39 for region 4T. The tail (T) was obtained by annealing of the oligonucleotides 59-GTACATTGCACTAAGAATGAGGATG-AAGCAAGTCGCAATGCAATTGATCGAAGATTTGTAAGC-39 and 59-GGCCGCTTACAAATCTTCGATCAATTGCATTGCGACTTGCT-TCATCCTCATTCTTAGTGCAAT-39. The specific primers used for amplification of pBMT-NSP5, pBMT-D2, pBMT-D3, pBMT-D4 and pBMT-D2/D3 were 59-CCGGAATTCATGTCTCTCAGCATTG-39 and 59-GCGGGATCCTTACAAATCTTCGATC-39; for pBMT-D1 and pBMT-D1/D3, 59-CGGGAATTCATGATTGGTAGGAG-39 and 59-GCGGGATCCTTACAAATCTTCGATC-39; and for pBMT-DC48, 59-CCGGAATTCATGTCTCTCAGCATTG-39 and 59-TGATCAGCG-AGCTCTAGC-39.
Localization to viroplasms and VLS formation. Transfection, infection with rotavirus and immunofluorescence for visualization of viroplasms were performed as described (Eichwald et al., 2002) . For VLS formation, cells were infected with rVV/NSP2 at a multiplicity of 3 p.f.u. per cell. After 1 h, cells were transfected with 2 mg plasmid and induced with 1 mM IPTG and 100 mg rifampicin ml 21 (Sigma) to prevent vaccinia virus morphogenesis (Grimley et al., 1970; Nagaya et al., 1970) . At 18 h post-infection, cells were fixed in 3?7 % paraformaldehyde and immunofluorescence was performed as described previously (Eichwald et al., 2002) .
Quantification of viroplasms. Cells were analysed using a confocal microscope (Axiovert; Zeiss). The area of the viroplasm was measured with the LSM 510 software version 2.02, using the overlay option that allows the measurement of functions such as length, angle, area and circumference. The analysis was performed on 20 cells per experiment and the results were plotted with the Microsoft Excel 9.0 program.
Yeast two-hybrid system. The yeast growth and the two-hybrid system were carried out as described previously (Visintin et al., 1999) . Briefly, plasmids were transformed into the L40 yeast strain using the lithium acetate transformation protocol (Gietz et al., 1992) . Positive clones were selected using auxotrophic markers for both plasmids (Trp and Leu) and prototrophy markers Uracil (U), Lys (K) and His (H). Yeast colonies grown on plates lacking histidine were obtained after 3 days of culture at 30 uC. For bgalactosidase assays, clones were lysed in liquid nitrogen and assayed for b-galactosidase activity as described previously (Breeden & Nasmyth, 1985) . Positive clones developed an intense blue colour after 15 min, while negative clones had not developed a blue colour after 12 h.
In vivo binding/immunoprecipitation assay. MA104 cells (0?5610 6 cells) were infected with rVV/NSP2 at a multiplicity of 3 p.f.u. cell 21 . After 1 h, cells were transfected with 2 mg of each NSP5 deletion mutant in 5 ml Transfectam (Promega) and induced with 1 mM IPTG. Four hours later, cells were incubated in methioninefree DMEM for 30 min. The medium was then replaced with DMEM containing 1?5 mg methionine l 21 and 1 mM IPTG, 100 mCi [ 35 S]methionine was added and the cells were labelled for 18 h. Before lysis, cells were washed twice with PBS, incubated for 10 min in 25 mM DSP (dithiobis-succinimidyl propionate; Pierce) in PBS at 4 uC, then washed three times in 2?5 ml 50 mM Tris/HCl, pH 7?5, 150 mM NaCl. Cells were lysed in 60 ml TNN lysis buffer [100 mM Tris/HCl, pH 8?0, 250 mM NaCl, 0?5 % NP-40, 16 protease inhibitor cocktail (Sigma)] for 10 min at 4 uC and centrifuged at 10 000 g for 5 min. Supernatants were immunoprecipitated as described previously (Eichwald et al., 2002) . Beads were washed twice in TNN and once in RIPA (100 mM Tris/HCl, pH 8, 150 mM NaCl, 1 % NP-40, 0?5 % deoxycholate, 0?1 % SDS) and the samples were analysed by SDS-PAGE (Laemmli, 1970) . Visualization of 35 Slabelled proteins was enhanced by fluorography using Amplify (Amersham). Autoradiography was performed at 270 uC using X-ray film (Kodak X-OMAT AR). Quantification of labelled proteins was carried out by densitometry on a Pharmacia LKB-Ultrascan XL densitometer and the values corrected according to the number of methionines in each protein. The ratio value was calculated using the formula: ratio=[a*(b/c)] day 21 , where a=densitometric value of the NSP5 deletion mutant, b=number of methionines in the fulllength NSP5, c=number of methionines in the deletion mutant NSP5 and d=densitometric value of NSP2. The mean was calculated from three independent experiments for each deletion mutant. The relative binding of full-length NSP5 was defined as 1.
RESULTS

Localization to viroplasms
With the aim of investigating the localization of NSP5 and NSP2 to viroplasms, we constructed NSP2-EGFP (enhanced green fluorescent protein) and NSP5-EGFP fusion proteins (in both cases at the N terminus of EGFP) and used them to obtain stable transfectants, which were subsequently infected with rotavirus. As shown in Fig. 1(A) , virus infection induced a rapid redistribution of the fusion proteins, with localization to viroplasms. However, while NSP2 appeared to occupy the central part of the viroplasms (Fig. 1B) , NSP5 was always visualized in a more external part as shown by the ring structure formed. This result was obtained using either NSP2 or NSP5 fused to EGFP with the corresponding partner protein visualized with a specific antibody. Similar results were obtained in non-transfected virus-infected cells using antibodies specific for NSP2 and NSP5, which showed that the two proteins co-localized, although a ring of NSP5 was still visible. These results were obtained with both SA11 and OSU viral strains, suggesting that they were independent of NSP6, a 93 amino acid protein encoded as an alternative ORF in SA11 gs11 mRNA, which is truncated in OSU (Mattion et al., 1991) .
Kinetics of viroplasm formation
We took advantage of the NSP2-EGFP stably transfected cells to follow, by confocal microspcopy, the assembly of viroplasms at various time points post-infection (from 2 to 24 h). Infection was also assessed by immunofluorescence with a specific anti-NSP5 antibody ( Fig. 2A, red) . The number of viroplasms was counted and their area determined using a specific option in the confocal microscope programme available in the instrument. While the area of single viroplasms increased with time from 6 h postinfection, the total number of viroplasms per cell diminished (Fig. 2B) . These results suggested a fusion between different viroplasms, supported by the fact that the shape of some of them appeared to be bean-like at 6 h post-infection (Fig. 2C) . In addition, a three-dimensional reconstruction of stacked images obtained at different levels in the horizontal plane (Fig. 3) suggested that the viroplasms were spherical structures by 24 h post-infection.
Yeast two-hybrid interaction between NSP5 mutants and NSP2
To characterize further the NSP2-NSP5 interaction, we used a yeast two-hybrid assay to identify the relevant NSP5 domains involved. The NSP5 deletion mutants presented in Fig. 4 were used as bait, with NSP2 fused to the herpes simplex virus transactivator protein, VP16 (Visintin et al., 1999) . Positive interaction was determined by growth in a medium lacking histidine followed by a b-galactosidase assay. All baits used in this assay were first tested to rule out possible transactivation activity in the absence of NSP2 and their expression checked by Western blotting (data not shown). As a result, neither wtNSP5 nor mutant D3 could be used in this assay since they showed transactivating activity per se.
The results obtained are shown in Fig. 4 . Mutants in which regions 2 or 4 were deleted could interact with NSP2, while mutants in which regions 1, 3 or the C-terminal T were deleted could not. These results indicated that the N-and C-terminal regions, as well as the central part (region 3, aa 81-130), of NSP5 play a crucial role in the interaction with NSP2.
Binding assay in mammalian cells
As an alternative method for studying NSP5-NSP2 interactions, we performed a binding/immunoprecipitation assay from total extracts of cells expressing NSP2 and various NSP5 mutants. For this purpose, the NSP2 gene was subcloned into the vaccinia virus insertion/expression vector pVOTE.1 and used to generate an IPTG-inducible recombinant vaccinia virus for NSP2 (rVV/NSP2) (Ward et al., 1995) . As shown in Fig. 5(A) , expression of NSP2 was obtained from IPTG-induced MA104 cells infected with rVV/NSP2 and metabolically labelled with [ 35 S]methionine. Following immunoprecipitation with anti-NSP2 serum, a single band of approximately 35 kDa with mobility identical to NSP2 from rotavirus strains OSU and SA11 was obtained.
To analyse the binding of NSP2 to NSP5, cells were infected with rVV/NSP2 at a multiplicity of 3 p.f.u. per cell, transfected with the different NSP5 deletion mutant constructs, induced with 1 mM IPTG and labelled overnight with [ 35 S]methionine. To stabilize the interaction, chemical crosslinking with DSP was performed in living cells, followed by lysis and immunoprecipitation with anti-NSP5. The relative binding was determined by densitometry of the bands obtained, following autoradiography of the SDSpolyacrylamide gel. The ratio was calculated as described in the Methods.
A representative binding assay is shown in Fig. 5(B) for some of the mutants. As expected, no cross-reactivity was observed in immunoprecipitations with anti-NSP5 in cells that were only infected with rVV/NSP2 and expressed no NSP5 (lane 1). In Fig. 5(C) , the relative binding of the different mutants is shown with respect to wtNSP5, which was defined as having a value of 1. Each NSP5 deletion mutant experiment was performed three times and the arithmetic mean was calculated. Deletion of region 1 (mutants D1, D1/D2 and D1/D3) had a profound effect on the ability to bind NSP2. Similarly, deletion of the C-terminal region T (mutants DT, D4T, D2/D4T and D3/DT) also resulted in strong binding impairment. These results were in agreement with the data obtained in the yeast two-hybrid experiments and indicated that the N and C termini are relevant for NSP2 binding. Independent deletion of other regions (such as regions 2, 3 and 4) suggested that they were not directly involved. Interestingly, region 3 appeared to have an inhibitory effect on the ability of the wild-type protein to bind NSP2, since deletion mutant D3 showed a relative binding twofold higher than wtNSP5. However, when regions 1 or T from this mutant were also deleted (D1/D3 or D3/DT), NSP2 binding was completely abolished.
Viroplasm localization is dependent on regions 1 and T
To demonstrate further that the N-and C-terminal regions of NSP5 are indeed the only ones required for interaction with NSP2 and localization to viroplasms, we turned to new constructs in which region 1 was fused to the N terminus of EGFP, and regions 4, T or both to the C terminus (Fig. 6) . The different constructs were used to study the formation of VLSs by co-transfection with NSP2 and localization in the viroplasm of virus-infected cells. VLSs were only obtained with mutants containing both region 1 and T, while localization to viroplasms could be seen even when region 1 was not present, i.e. in EGFP-4T. This is likely to be the consequence of EGFP-4T interaction with viral NSP5, which depends on NSP5 C-terminal residues (Torres-Vega et al., 2000; Eichwald et al., 2002) . Table 1 summarizes the interactions of EGFP-NSP5 domain fusion constructs in terms of localization to the viroplasm in virus-infected cells and formation of VLSs when cotransfected with NSP2. These results are consistent with those obtained with the yeast two-hybrid analysis and the in vivo binding/immunoprecipitation assay, in which the N-terminal region and the C-terminal tail of NSP5 were characterized as the two regions necessary for NSP2 binding.
DISCUSSION
The non-fusogenic mammalian orthoreoviruses replicate and assemble in cytoplasmic phase-dense inclusions in infected cells. These inclusions contain viral dsRNA (Silverstein & Schur, 1970) , viral proteins and partially assembled viral particles (Rhim et al., 1962; Dales et al., 1965) . In the case of rotaviruses, the inclusion bodies, called viroplasms, are globular structures identified as the machinery of virus replication. Immunogold staining with antibodies against NSP2 and NSP5 has suggested that both proteins localize in the external part of the globular structure of the viroplasms (Petrie et al., 1984) . Here, we used confocal microscopy to investigate the localization in viroplasms of NSP2 and NSP5 using stable transfectants of NSP5-EGFP and NSP2-EGFP, followed by rotavirus infection. Magnification of the viroplasm images showed NSP2 and NSP5 co-localization, although NSP5 appeared relatively concentrated in a more external region with respect to NSP2. There are at least two possible interpretations of this observation: (i) it represents a relative different distribution of the two proteins within viroplasms; or (ii) it is the consequence of different reactivity or accessibility of the proteins to the antibodies. In fact, in other experiments, co-immunoprecipitation carried out with anti-NSP2 or anti-NSP5 showed that, while anti-NSP5 was able to co-precipitate NSP2, anti-NSP2 was not (Afrikanova et al., 1998; C. Eichwald & O. R. Burrone, unpublished data) . In addition, in double immunofluorescence studies we have observed that incubating first with an anti-NSP5 serum blocks binding of anti-NSP2, while the reverse does not (data not shown). Further studies are needed to clarify this issue. Viroplasms appear to be dynamic structures, with an increase in size and a reduction in number over time, suggesting a fusion process between them. Moreover, the stack images suggested that viroplasms are well-defined spherical structures. In reoviruses, it has also been reported that sNS, the non-structural protein homologous to rotavirus NSP2 with ssRNA binding activity and capacity to form higher-order homo-oligomeric structures (Huismans & Joklik, 1976; Richardson & Furuichi, 1985; Gillian & Nibert, 1998; Gillian et al., 2000) , can also form inclusionbody-like structures when co-expressed with reovirus protein mNS (Becker et al., 2003) . NS2 of bluetongue virus and rotavirus NSP2 have been considered to be proteins of similar function, since they share NTPase activity, non-specific ssRNA binding and localization to inclusions bodies Fillmore et al., 2002) . However, there are no reports describing the ability of NS2 to form VLSs when co-expressed with other viral proteins. With regard to rotavirus NSP5, no analogous function has been reported for any other viral protein of viruses in the Reoviridae family.
A main goal of our study was to map the binding sites of NSP5 for NSP2. For this purpose we used two different in vivo strategies: (i) a yeast two-hybrid system; and (ii) an in vivo binding/immunoprecipitation assay in mammalian cells. Essentially, the two methods gave similar results, indicating the N-and C-terminal parts of NSP5 as the main components required for the interaction. The results of the yeast two-hybrid system suggested that the central region of 30 amino acids (region 3) could also be important for NSP2 binding. However, the direct assay of the mutant lacking only region 3 (D3) was not possible because the construct LexA-D3 was transactivating in the absence of NSP2-VP16. This was also the case for wtNSP5 and mutant D1. In the immunoprecipitation assay, however, deletion of region 3 produced an increased NSP2 binding activity, suggesting not only that it is not involved in binding, but also that it behaves as an inhibitory domain. On the other hand, the relevant roles of regions 1 and 4T were clearly confirmed. In addition, these two terminal regions were able to confer to EGFP, when fused at the N and C terminus, respectively, the ability to localize to viroplasms in virus-infected cells and to form VLSs in cells expressing NSP2. The fact that the construct containing only the C terminal fusion 4T from NSP5 was unable to form VLSs suggested that region 1 indeed plays a crucial role in NSP2 binding, as has been previously proposed (Eichwald et al., 2002) .
